EPONYMS IN NEURORADIOLOGY

EPONYMS IN NEURORADIOLOGY

 

We are also pleased to offer student members, medical students, interns & junior doctors the opportunity to deliver a 3-minute presentation as part of our Eponyms in Neuroradiology Session.

​

​The winner of the best Eponyms in Neuroradiology presentation will receive complimentary registration to the 2027 ANZSNR ASM.

​

​Abstracts submissions are invited to illustrate an eponym commonly used in neuroradiology to designate:

​​

• a disease or syndrome

• a feature of a disease

• a technique, instrument or physics feature

• an anatomic structure

​​

Authors will be encouraged to link the past to the present.

​

Background

 

An eponym refers to the name of a disease, a structure, or a technical feature based on or derived from the name of a person (real or fictitious). The word is derived from the ancient Greek ἐπώνυμος (epṓnymos), from ἐπί (epí, “upon”) and ὄνυμα (ónyma, “name”).

​

Most commonly, eponyms refer to the person who first discovered and described the condition, though some eponyms relate to a patient (e.g., Lou Gehrig's disease).

​

In neuroradiology, eponyms are commonly used in reporting and communication, as they provide an efficient, concise, and short way of describing signs, syndromes, structures, techniques, or artefacts.

​

Importantly, eponyms offer a cultural bridge, linking the current standards of practice to the historical foundations of our discipline. Moreover, eponyms honour the contribution of the pioneers in in our field who developed modern neuroradiology as we know it. 

 

Aims

 

 In creating a session on “Eponyms in Neuroradiology”, ANZSNR pursues twofold goals:

​

• to illustrate (little known) eponyms commonly used and correlate their origin with current day neuroradiological practice.

• to offer trainees a low-threshold opportunity to actively participate in the ANZSNR ASM, allowing them to gain experience in preparing an abstract and delivering a short presentation.

​

We encourage authors to explore the use of eponyms across different languages, cultural contexts, ancient world mythologies, and medical traditions.

​

​The program planning committee will prioritise abstracts that report relatively little-known, yet clinically highly relevant eponyms. Presenters are encouraged to link the past to the present, i.e., translate the historical and cultural significance of the eponym to the clinical value in modern neuroradiology and/or neuroscience.

​